Synopsis
Synopsis
0
VMF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 3,5,3',5'-tetraiodothyronine
2. Berlthyrox
3. Dexnon
4. Eferox
5. Eltroxin
6. Eltroxine
7. Euthyrox
8. Eutirox
9. L Thyrox
10. L Thyroxin Beta
11. L Thyroxin Henning
12. L Thyroxine
13. L Thyroxine Roche
14. L-3,5,3',5'-tetraiodothyronine
15. L-thyrox
16. L-thyroxin Beta
17. L-thyroxin Henning
18. L-thyroxine
19. L-thyroxine Roche
20. Lvothyrox
21. Levo T
22. Levo-t
23. Levothroid
24. Levothyroid
25. Levothyroxin Deladande
26. Levothyroxin Delalande
27. Levothyroxine
28. Levothyroxine Sodium
29. Levoxine
30. Levoxyl
31. Novothyral
32. Novothyrox
33. O-(4-hydroxy-3,5-diiodophenyl) 3,5-diiodo-l-tyrosine
34. O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine
35. Oroxine
36. Sodium Levothyroxine
37. Synthroid
38. Synthrox
39. T4 Thyroid Hormone
40. Thevier
41. Thyrax
42. Thyroid Hormone, T4
43. Thyroxin
44. Thyroxine
45. Tiroidine
46. Tiroxina Leo
47. Unithroid
1. 25416-65-3
2. Levothyroxine Sodium
3. L-thyroxine Sodium Xhydrate
4. Levothyroxine Sodium Hydrate
5. L-thyroxine Sodium Hydrate
6. Monosodium L-thyroxine Hydrate
7. 31178-59-3
8. Chebi:6447
9. Levothroid
10. Synthroid
11. Levothyrox
12. Levaxin
13. Levoxyl
14. Oroxine
15. Soloxine
16. Eferox
17. Sodium;(2s)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoate;hydrate
18. B82379r9w0
19. Thyroxine Sodium
20. Levo-t
21. Liotrix (t4)
22. Thyroxine Sodium Salt
23. L-tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, Monosodium Salt, Monohydrate
24. Latequatro
25. Letequatro
26. Levoroxin
27. Levotiron
28. Tiroxina
29. Tivoral
30. Levo-tiroxina Glaxo
31. Nsc-259940
32. L-tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, Monosodium Salt, Hydrate
33. Unii-b82379r9w0
34. Levothroid (tn)
35. Synthroid (tn)
36. Levoxyl (tn)
37. Levothyroxine Sodium [usp:inn:jan]
38. Starbld0009614
39. L-thyroxin Monosodium Salt
40. T4 (liotrix)
41. Levothyroxine Sodium (usp)
42. Schembl2327406
43. Chembl2103741
44. L-thyroxine Sodium Salt Monohydrate
45. 3,3',5,5'-tetraiodo-l-thyronine Monosodium Salt Hydrate
46. Levothyroxine Sodium Hydrate (jp17)
47. Mfcd06408007
48. Akos015895962
49. Ks-1237
50. D01010
51. E78443
52. Levothyroxine Sodium Monohydrate [who-ip]
53. 3,3',5,5'-tetraiodo-l-thyronine Monosodium Salt
54. A817851
55. Q27107209
56. Levothyroxinum Natricum Monohydrate [who-ip Latin]
57. Sodium 2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoate Hydrate
58. Sodium (s)-2-amino-3-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)propanoate Xhydrate
Molecular Weight | 816.87 g/mol |
---|---|
Molecular Formula | C15H12I4NNaO5 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 5 |
Exact Mass | 816.6792 g/mol |
Monoisotopic Mass | 816.6792 g/mol |
Topological Polar Surface Area | 96.6 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 426 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 8 | |
---|---|
Drug Name | Levo-t |
Drug Label | Levothyroxine sodium tablets, USP contains synthetic crystalline L-3,3',5,5'-tetraiodothyronine sodium salt [levothyroxine (T4) sodium]. Synthetic T4 is identical to that produced in the human thyroid gland.Levothyroxine (T4) sodium has an empir |
Active Ingredient | Levothyroxine sodium |
Dosage Form | Tablet |
Route | Oral |
Strength | 0.05mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium; 0.112mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium; 0.2mg **see current annual edition, 1.8 description of spe |
Market Status | Prescription |
Company | Alara Pharm |
2 of 8 | |
---|---|
Drug Name | Levothroid |
PubMed Health | Thyroid Supplement (By mouth) |
Drug Classes | Diagnostic Agent, Thyroid Function, Thyroid Supplement |
Drug Label | LEVOTHROID (levothyroxine sodium tablets, USP) contains synthetic crystalline L-3,3',5,5'-tetraiodothyronine sodium salt [levothyroxine (T4) sodium]. Synthetic T4 is identical to that produced in the human thyroid gland. Levothyroxine (T4) sodiu |
Active Ingredient | Levothyroxine sodium |
Dosage Form | Tablet |
Route | Oral |
Strength | 0.05mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium; 0.112mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium; 0.2mg **see current annual edition, 1.8 description of spe |
Market Status | Prescription |
Company | Lloyd |
3 of 8 | |
---|---|
Drug Name | Levothyroxine sodium |
Active Ingredient | Levothyroxine sodium |
Dosage Form | Tablet; Powder; Injectable |
Route | injection; Oral; Intravenous |
Strength | 0.05mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium; 200mcg/vial; 0.112mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium; 0.2mg **see current annual edition, 1.8 descr |
Market Status | Prescription |
Company | Fresenius Kabi Usa; Mylan |
4 of 8 | |
---|---|
Drug Name | Levoxyl |
Drug Label | LEVOXYL (levothyroxine sodium tablets, USP) contain synthetic crystalline L-3,3,5,5-tetraiodothyronine sodium salt [levothyroxine (T4) sodium]. Synthetic T4 is identical to that produced in the human thyroid gland. Levothyroxine (T4) sodiu... |
Active Ingredient | Levothyroxine sodium |
Dosage Form | Tablet |
Route | Oral |
Strength | 0.05mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium; 0.112mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium; 0.2mg **see current annual edition, 1.8 description of spe |
Market Status | Prescription |
Company | King Pharms R And D |
5 of 8 | |
---|---|
Drug Name | Levo-t |
Drug Label | Levothyroxine sodium tablets, USP contains synthetic crystalline L-3,3',5,5'-tetraiodothyronine sodium salt [levothyroxine (T4) sodium]. Synthetic T4 is identical to that produced in the human thyroid gland.Levothyroxine (T4) sodium has an empir |
Active Ingredient | Levothyroxine sodium |
Dosage Form | Tablet |
Route | Oral |
Strength | 0.05mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium; 0.112mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium; 0.2mg **see current annual edition, 1.8 description of spe |
Market Status | Prescription |
Company | Alara Pharm |
6 of 8 | |
---|---|
Drug Name | Levothroid |
PubMed Health | Thyroid Supplement (By mouth) |
Drug Classes | Diagnostic Agent, Thyroid Function, Thyroid Supplement |
Drug Label | LEVOTHROID (levothyroxine sodium tablets, USP) contains synthetic crystalline L-3,3',5,5'-tetraiodothyronine sodium salt [levothyroxine (T4) sodium]. Synthetic T4 is identical to that produced in the human thyroid gland. Levothyroxine (T4) sodiu |
Active Ingredient | Levothyroxine sodium |
Dosage Form | Tablet |
Route | Oral |
Strength | 0.05mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium; 0.112mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium; 0.2mg **see current annual edition, 1.8 description of spe |
Market Status | Prescription |
Company | Lloyd |
7 of 8 | |
---|---|
Drug Name | Levothyroxine sodium |
Active Ingredient | Levothyroxine sodium |
Dosage Form | Tablet; Powder; Injectable |
Route | injection; Oral; Intravenous |
Strength | 0.05mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium; 200mcg/vial; 0.112mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium; 0.2mg **see current annual edition, 1.8 descr |
Market Status | Prescription |
Company | Fresenius Kabi Usa; Mylan |
8 of 8 | |
---|---|
Drug Name | Levoxyl |
Drug Label | LEVOXYL (levothyroxine sodium tablets, USP) contain synthetic crystalline L-3,3,5,5-tetraiodothyronine sodium salt [levothyroxine (T4) sodium]. Synthetic T4 is identical to that produced in the human thyroid gland. Levothyroxine (T4) sodiu... |
Active Ingredient | Levothyroxine sodium |
Dosage Form | Tablet |
Route | Oral |
Strength | 0.05mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium; 0.112mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium; 0.2mg **see current annual edition, 1.8 description of spe |
Market Status | Prescription |
Company | King Pharms R And D |
H - Systemic hormonal preparations, excl. sex hormones and insulins
H03 - Thyroid therapy
H03A - Thyroid preparations
H03AA - Thyroid hormones
H03AA01 - Levothyroxine sodium
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Bioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-06-23
Pay. Date : 2013-09-26
DMF Number : 24402
Submission : 2011-10-20
Status : Active
Type : II
Certificate Number : CEP 2011-315 - Rev 02
Issue Date : 2023-11-08
Type : Chemical
Substance Number : 401
Status : Valid
NDC Package Code : 46014-1013
Start Marketing Date : 2011-10-20
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-03-23
Pay. Date : 2017-03-06
DMF Number : 31203
Submission : 2017-01-31
Status : Active
Type : II
Certificate Number : R1-CEP 2017-040 - Rev 00
Issue Date : 2023-04-03
Type : Chemical
Substance Number : 401
Status : Valid
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38710
Submission : 2023-09-29
Status : Active
Type : II
NDC Package Code : 54893-0125
Start Marketing Date : 2023-09-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-07-10
Pay. Date : 2015-05-05
DMF Number : 29098
Submission : 2015-03-14
Status : Active
Type : II
Certificate Number : R1-CEP 2016-280 - Rev 01
Issue Date : 2023-05-26
Type : Chemical
Substance Number : 401
Status : Valid
Date of Issue : 2021-02-26
Valid Till : 2023-06-22
Written Confirmation Number : WC-0404A3
Address of the Firm :
NDC Package Code : 69575-4001
Start Marketing Date : 2015-11-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (20kg/20kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Aging Life Science Co., Ltd.
Registration Date : 2020-11-25
Registration Number : 20201125-209-J-789
Manufacturer Name : Azico Biophore India Private Limited
Manufacturer Address : Plot Number 40/A, Sy. No. 13,15,16,51,52 & 182, JN.Pharma city, Thanam(V), Anakapalli District 531021, Andhra Pradesh, India
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-01-15
Pay. Date : 2012-12-21
DMF Number : 4789
Submission : 1983-01-06
Status : Active
Type : II
Certificate Number : CEP 1998-141 - Rev 11
Issue Date : 2023-09-26
Type : Chemical
Substance Number : 401
Status : Valid
Registration Number : 217MF10456
Registrant's Address : Biochemiesstrasse 10, 6250 Kundl, Austria
Initial Date of Registration : 2005-08-24
Latest Date of Registration : --
NDC Package Code : 43858-410
Start Marketing Date : 2010-02-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 29526
Submission : 2015-06-29
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-01-30
Pay. Date : 2013-01-15
DMF Number : 14715
Submission : 2000-02-01
Status : Active
Type : II
Certificate Number : R1-CEP 1998-048 - Rev 06
Issue Date : 2023-07-05
Type : Chemical
Substance Number : 401
Status : Valid
Registration Number : 221MF10168
Registrant's Address : Am Kraftwerk 6, D-66450 Bexbach, Germany
Initial Date of Registration : 2009-07-30
Latest Date of Registration : --
NDC Package Code : 67891-001
Start Marketing Date : 2003-04-18
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Registrant Name : Samnam Pharmaceutical Co., Ltd.
Registration Date : 2020-01-10
Registration Number : 20181023-209-J-104(3)
Manufacturer Name : Peptido GmbH
Manufacturer Address : Am Kraftwerk 6, 66450 Bexbach, Germany
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?